SpringWorks Therapeutics, Inc.
SWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,678 | $2,304 | $1,386 | $3,006 |
| - Cash | $70 | $176 | $67 | $104 |
| + Debt | $8 | $7 | $5 | $1 |
| Enterprise Value | $2,617 | $2,135 | $1,324 | $2,903 |
| Revenue | $192 | $5 | $6 | $0 |
| % Growth | 3,417.3% | -11.4% | – | – |
| Gross Profit | $179 | $5 | $4 | -$0 |
| % Margin | 93.4% | 92.3% | 69.2% | – |
| EBITDA | -$275 | -$341 | -$276 | -$173 |
| % Margin | -143.4% | -6,266.7% | -4,482.2% | – |
| Net Income | -$258 | -$325 | -$277 | -$173 |
| % Margin | -134.7% | -5,968.5% | -4,513% | – |
| EPS Diluted | -3.48 | -5.15 | -5.21 | -3.59 |
| % Growth | 32.4% | 1.2% | -45.1% | – |
| Operating Cash Flow | -$176 | -$223 | -$162 | -$128 |
| Capital Expenditures | -$4 | -$7 | -$10 | -$2 |
| Free Cash Flow | -$180 | -$230 | -$172 | -$130 |